Matches in Wikidata for { <http://www.wikidata.org/entity/Q59606771> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q59606771 description "article published in 2017" @default.
- Q59606771 description "article scientifique publié en 2017" @default.
- Q59606771 description "wetenschappelijk artikel" @default.
- Q59606771 description "наукова стаття, опублікована у квітні 2017" @default.
- Q59606771 name "Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease" @default.
- Q59606771 name "Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease" @default.
- Q59606771 type Item @default.
- Q59606771 label "Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease" @default.
- Q59606771 label "Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease" @default.
- Q59606771 prefLabel "Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease" @default.
- Q59606771 prefLabel "Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease" @default.
- Q59606771 P1433 Q59606771-D2D0F806-496F-4370-A9A8-B1F7A8EE3B80 @default.
- Q59606771 P1476 Q59606771-FD73C839-E576-4041-9F45-8B013AF775C4 @default.
- Q59606771 P2093 Q59606771-2D8CE2BF-D768-4BA5-937F-8BCA5F865F53 @default.
- Q59606771 P2093 Q59606771-2FB6D081-6038-499D-9300-7B532944C081 @default.
- Q59606771 P2093 Q59606771-33A66EF6-0828-4BDD-9444-775BCB8BC837 @default.
- Q59606771 P2093 Q59606771-5DDE8CE6-64BD-4BA3-940C-F80503DC7297 @default.
- Q59606771 P2093 Q59606771-5F716882-26AB-4769-99E1-C7DCEFCCB7CB @default.
- Q59606771 P2093 Q59606771-62C7169E-05B7-4BC4-8CBE-459E40C140DB @default.
- Q59606771 P2093 Q59606771-7BDA95A7-1CE9-4738-8F80-438383478BC4 @default.
- Q59606771 P2093 Q59606771-93B7325A-1FEF-4B26-B46F-F22C8834CED9 @default.
- Q59606771 P2860 Q59606771-1B71FAD8-F6B5-45B6-B7E3-9F79916C4F86 @default.
- Q59606771 P2888 Q59606771-2A2A2C34-E0F0-4944-BD56-16BF7AD61CD7 @default.
- Q59606771 P31 Q59606771-2001540E-543C-405A-868E-A00F95FB25FC @default.
- Q59606771 P356 Q59606771-79DB728B-683C-42C6-AC48-38524A6539B6 @default.
- Q59606771 P433 Q59606771-82C619F5-7946-4ABA-BCD5-926EB623D77E @default.
- Q59606771 P478 Q59606771-D0C83E04-64D0-4B03-AF41-E4D3D059F0DB @default.
- Q59606771 P577 Q59606771-BDE3BE99-4FC3-4886-9BC5-C3D177E176FE @default.
- Q59606771 P6179 Q59606771-F395B1C6-6C24-4BE7-B954-48E0936C1F17 @default.
- Q59606771 P921 Q59606771-B769DA95-FC31-49E1-9331-9C140BAD90F2 @default.
- Q59606771 P921 Q59606771-C9CA116A-F67D-4DC7-AC93-7E9090A0917B @default.
- Q59606771 P356 S41100-017-0098-7 @default.
- Q59606771 P1433 Q50815312 @default.
- Q59606771 P1476 "Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease" @default.
- Q59606771 P2093 "Anna Katayama" @default.
- Q59606771 P2093 "Koji Mugishima" @default.
- Q59606771 P2093 "Saori Sakai" @default.
- Q59606771 P2093 "Shuichi Tsuruoka" @default.
- Q59606771 P2093 "Tomoyuki Otsuka" @default.
- Q59606771 P2093 "Yuichiro Sumi" @default.
- Q59606771 P2093 "Yukinao Sakai" @default.
- Q59606771 P2093 "Yusuke Otsuka" @default.
- Q59606771 P2860 Q79700757 @default.
- Q59606771 P2888 s41100-017-0098-7 @default.
- Q59606771 P31 Q13442814 @default.
- Q59606771 P356 "10.1186/S41100-017-0098-7" @default.
- Q59606771 P433 "1" @default.
- Q59606771 P478 "3" @default.
- Q59606771 P577 "2017-04-24T00:00:00Z" @default.
- Q59606771 P6179 "1083833644" @default.
- Q59606771 P921 Q1054718 @default.
- Q59606771 P921 Q3025883 @default.